Methodological problems in assessing therapeutic efficacy in patients with dementia
- PMID: 1596597
- DOI: 10.2165/00002512-199202020-00001
Methodological problems in assessing therapeutic efficacy in patients with dementia
Similar articles
-
Cholinesterase inhibitors in the treatment of Alzheimer's disease and related dementias.Clin Geriatr Med. 2004 Feb;20(1):59-68. doi: 10.1016/j.cger.2003.11.002. Clin Geriatr Med. 2004. PMID: 15062487 No abstract available.
-
Galantamine for vascular dementia: some answers, some questions.Lancet. 2002 Apr 13;359(9314):1265-6. doi: 10.1016/S0140-6736(02)08283-1. Lancet. 2002. PMID: 11965268 No abstract available.
-
Citicoline in vascular cognitive impairment and vascular dementia after stroke.Stroke. 2011 Jan;42(1 Suppl):S40-3. doi: 10.1161/STROKEAHA.110.606509. Epub 2010 Dec 16. Stroke. 2011. PMID: 21164117 Review.
-
[Dementia-related diseases. Propentofyllin--a neuroprotective glia cell modulator].Nervenarzt. 1998 Feb;69(2 Suppl Propentofy):1-4. Nervenarzt. 1998. PMID: 9532231 German. No abstract available.
-
HWA 285 (propentofylline)--a new compound for the treatment of both vascular dementia and dementia of the Alzheimer type.Ann N Y Acad Sci. 1996 Jan 17;777:404-9. doi: 10.1111/j.1749-6632.1996.tb34453.x. Ann N Y Acad Sci. 1996. PMID: 8624121 Review.
Cited by
-
Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders.Drugs Aging. 1992 Jul-Aug;2(4):262-86. doi: 10.2165/00002512-199202040-00002. Drugs Aging. 1992. PMID: 1504442 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical